Probing the early upper respiratory responses to SARS‐CoV‐2

Since the emergence of the novel respiratory coronavirus, designated SARS‐CoV‐2 in 2019, there have been more than 2.5 million deaths worldwide, and the numbers continue to rise (Zhu et al., 2020). ( 2020) uses an innovative approach to examine the impact of early SARS‐CoV‐2 infection on the innate immune response in the upper respiratory system. [...]it is unknown if this a specific feature of SARS‐CoV‐2 infection where the virus is actively involved in the regulation of host inflammatory mediators, or if this is part of the host process in the tight regulation of the innate immune response during early infection.